Get started
Author

Natalie Gahres

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
2006 · Ashraf Badros, Dianna Weikel, et al. · Journal of Clinical Oncology · 593
Immune effector cell–associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
2020 · Noa G Holtzman, Hao Xie, et al. · Neuro-Oncology · 119
Phase II Study of G3139, a Bcl-2 Antisense Oligonucleotide, in Combination With Dexamethasone and Thalidomide in Relapsed Multiple Myeloma Patients
2005 · Ashraf Z. Badros, Olga Goloubeva, et al. · Journal of Clinical Oncology · 98
The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
2021 · Forat Lutfi, Noa G. Holtzman, et al. · British Journal of Haematology · 30
Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma
2020 · Forat Lutfi, Noa Holtzman, et al. · British Journal of Haematology · 24
PDF
Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
2005 · Ashraf Badros, Natalie Gahres · PubMed · 10
Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predictive Biomarkers and Clinical Outcomes
2019 · Noa G. Holtzman, Soren M. Bentzen, et al. · Blood · 6
Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
2019 · Ali Bukhari, Vivek Kesari, et al. · Blood · 4
Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
2023 · Hanan Alkhaldi, Olga Goloubeva, et al. · Transplantation Proceedings · 3
Early imaging biomarker assessment to predict long-term responses for large B-cell lymphoma (LBCL) after CAR-T therapy.
2019 · Reza Sirous, Ali Abbas Bukhari, et al. · Journal of Clinical Oncology · 3
Shifting Gears from Transplant to CAR T: Creating a Cell Therapy Nurse Coordinator Role
2019 · Elizabeth Hutnick, Kathleen Ruehle, et al. · Transplantation and Cellular Therapy · 1
PDF
Long-Term Outcomes of Busulfan, Fludarabine and 400 Cgy Total Body Irradiation Versus Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Hematologic Diseases: A Large Single Center Experience
2020 · Justin N. Malinou, Hanan Alkhaldi, et al. · Blood
Works count: 12
Citation count: 891
H-index: 6
I10-index: 6
Year
Topic
Type